Medy-Tox disclosed that it has set October 29, 2026 as the record date to confirm shareholders entitled to the interim (quarterly) dividend.

Medy-Tox said that, under a board resolution dated October 14, 2026, it has set October 29, 2026 as the record date to confirm shareholders entitled to the interim (quarterly) dividend. The company explained that it will confirm entitlement based on the record date alone, without closing its shareholder register. Details such as the dividend amount are not included in the original text of this filing and can be found in the cash and in-kind dividend decision filing published the same day.

1. 01

   The purpose of the filing is to confirm shareholders entitled to the interim (quarterly) dividend, with the record date set at October 29, 2026.

2. 02

   The company said it will confirm shareholders entitled to the dividend based on the record date alone, without closing the shareholder register.

3. 03

   The board resolution date is October 14, 2026, and the company said the dividend is based on Article 58 (Dividends of Earnings) of its articles of incorporation.

4. 04

   A related filing includes the cash and in-kind dividend decision for October 14, 2026.

An AI model translated the Korean summary of this filing into English; every number is carried over from the Korean original. Reference information, not investment advice.

Key figures

Record date

October 29, 2026

Board resolution date (decision date)

October 14, 2026

Outside directors present (persons)

2

Filing facts

Filing type

Dividend

Report name

Record Date for Interim (Quarterly) Dividend

Filed

Oct 14, 2026

Receipt number

20261014900224